Bayer A S, Crowell D, Nast C C, Norman D C, Borrelli R L
Department of Medicine, Harbor-UCLA, Torrance, CA 90509.
Chest. 1990 Mar;97(3):611-7. doi: 10.1378/chest.97.3.611.
The distribution of antibiotics into cardiac valvular tissues is incompletely understood. By integrative computer modeling, we have used previously obtained pharmacokinetic data in experimental endocarditis to characterize aminoglycoside distribution within various geographic sectors of aortic vegetations of rabbits and humans in the current study. In rabbits with pseudomonal aortic endocarditis receiving a standard regimen of amikacin (15 mg/kg every eight hours), sub-MBC levels of the drug for the infecting organism were calculated in the center of 0.38-cm vegetations; this occurred despite supra-MBC levels calculated in plasma and more peripheral loci of the vegetation. In contrast, with a high-dose regimen of amikacin (40 mg/kg every eight hours), supra-MBC drug levels were calculated throughout the entire vegetation for at least 50 percent of the dosing interval. Using similar computer-generated approaches, these data in the rabbit were approximately in simulated aminoglycoside penetration of 10-mm human aortic vegetations. Aminoglycoside regimens designed to yield supra-MBC serum levels in both normal and rapid drug eliminators consistently achieved sub-MBC levels in the center of the vegetation. Computer simulations also confirmed that daily doses of aminoglycoside at least two to four times higher than those ordinarily recommended are necessary to consistently achieve uniform supra-MBC intravegetation levels for an entire dosing interval. Such computer-generated data support the concept of maldistribution of aminoglycosides in aortic endocarditis and provide a rationale for investigating the use of high-dose regimens of aminoglycoside in treating experimental endocarditis.
抗生素在心脏瓣膜组织中的分布尚未完全明确。在本研究中,通过整合计算机建模,我们利用先前在实验性心内膜炎中获得的药代动力学数据,来描述氨基糖苷类药物在兔和人类主动脉赘生物不同区域的分布特征。在患有铜绿假单胞菌性主动脉心内膜炎并接受阿米卡星标准治疗方案(每八小时15mg/kg)的兔中,计算得出在直径0.38cm赘生物中心部位,该药物对感染病原体的浓度低于最低杀菌浓度(sub-MBC);尽管在血浆及赘生物更外周部位计算得出的浓度高于最低杀菌浓度(supra-MBC)。相比之下,在采用阿米卡星高剂量方案(每八小时40mg/kg)时,在整个给药间隔至少50%的时间内,整个赘生物内的药物浓度均高于最低杀菌浓度。使用类似的计算机模拟方法,兔体内的数据大致模拟了氨基糖苷类药物在10mm人类主动脉赘生物中的渗透情况。旨在使正常及药物快速消除者血清浓度均高于最低杀菌浓度的氨基糖苷类治疗方案,在赘生物中心部位始终达到低于最低杀菌浓度的水平。计算机模拟还证实,为了在整个给药间隔内始终在赘生物内达到均匀的高于最低杀菌浓度的水平,氨基糖苷类药物的每日剂量至少需要比通常推荐剂量高两到四倍。这些计算机模拟数据支持了氨基糖苷类药物在主动脉心内膜炎中分布不均的概念,并为研究高剂量氨基糖苷类治疗方案在实验性心内膜炎治疗中的应用提供了理论依据。